MeVis Medical Solutions AG (FRA:M3V) Piotroski F-Score: 8 (As of Jun. 27, 2026) — 33% Above Median


FRA:M3V MeVis Medical Solutions AG FRA:M3V
66 GF Score
Price €23.20
GF Value €22.52
! 4 Warning Signs
View Full Analysis

What is MeVis Medical Solutions AG Piotroski F-Score?

MeVis Medical Solutions AG FRA:M3V 66 Piotroski F-Score is 8 as of Jun. 27, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 652 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 97.39% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MeVis Medical Solutions AG has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for MeVis Medical Solutions AG's Piotroski F-Score or its related term are showing as below:

FRA:M3V' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 8
Current: 8

During the past 13 years, the highest Piotroski F-Score of MeVis Medical Solutions AG was 8. The lowest was 4. And the median was 6.

MeVis Medical Solutions AG  (FRA:M3V) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


MeVis Medical Solutions AG Piotroski F-Score Related Terms


MeVis Medical Solutions AG Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for MeVis Medical Solutions AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeVis Medical Solutions AG Piotroski F-Score Chart

MeVis Medical Solutions AG Annual Data
Trend Dec15 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 6.00 7.00 6.00 8.00

MeVis Medical Solutions AG Semi-Annual Data
Jun16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 6.00 0.00 8.00 0.00

FRA:M3V vs VEEV, BTSG, TEM: Piotroski F-Score Comparison

For the Health Information Services subindustry, MeVis Medical Solutions AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeVis Medical Solutions AG Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's Piotroski F-Score falls into.


FRA:M3V
66GF Score
MeVis Medical Solutions AG FRA:M3V
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep25) TTM:Last Year (Sep24) TTM:
Net Income was €3.17 Mil.
Cash Flow from Operations was €3.88 Mil.
Revenue was €16.06 Mil.
Gross Profit was €15.69 Mil.
Average Total Assets from the begining of this year (Sep24)
to the end of this year (Sep25) was (26.484 + 25.886) / 2 = €26.185 Mil.
Total Assets at the begining of this year (Sep24) was €26.48 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Total Current Assets was €9.05 Mil.
Total Current Liabilities was €5.72 Mil.
Net Income was €4.56 Mil.

Revenue was €16.97 Mil.
Gross Profit was €16.48 Mil.
Average Total Assets from the begining of last year (Sep23)
to the end of last year (Sep24) was (28.054 + 26.484) / 2 = €27.269 Mil.
Total Assets at the begining of last year (Sep23) was €28.05 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Total Current Assets was €9.64 Mil.
Total Current Liabilities was €6.36 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MeVis Medical Solutions AG's current Net Income (TTM) was 3.17. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MeVis Medical Solutions AG's current Cash Flow from Operations (TTM) was 3.88. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep24)
=3.166/26.484
=0.11954388

ROA (Last Year)=Net Income/Total Assets (Sep23)
=4.561/28.054
=0.16257931

MeVis Medical Solutions AG's return on assets of this year was 0.11954388. MeVis Medical Solutions AG's return on assets of last year was 0.16257931. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

MeVis Medical Solutions AG's current Net Income (TTM) was 3.17. MeVis Medical Solutions AG's current Cash Flow from Operations (TTM) was 3.88. ==> 3.88 > 3.17 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep24 to Sep25
=0/26.185
=0

Gearing (Last Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=0/27.269
=0

MeVis Medical Solutions AG's gearing of this year was 0. MeVis Medical Solutions AG's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep25)=Total Current Assets/Total Current Liabilities
=9.053/5.72
=1.58269231

Current Ratio (Last Year: Sep24)=Total Current Assets/Total Current Liabilities
=9.644/6.357
=1.5170678

MeVis Medical Solutions AG's current ratio of this year was 1.58269231. MeVis Medical Solutions AG's current ratio of last year was 1.5170678. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

MeVis Medical Solutions AG's number of shares in issue this year was 1.82. MeVis Medical Solutions AG's number of shares in issue last year was 1.82. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=15.692/16.061
=0.97702509

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=16.482/16.972
=0.97112892

MeVis Medical Solutions AG's gross margin of this year was 0.97702509. MeVis Medical Solutions AG's gross margin of last year was 0.97112892. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep24)
=16.061/26.484
=0.60644163

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep23)
=16.972/28.054
=0.60497612

MeVis Medical Solutions AG's asset turnover of this year was 0.60644163. MeVis Medical Solutions AG's asset turnover of last year was 0.60497612. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MeVis Medical Solutions AG has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
MeVis Medical Solutions AG (FRA:M3V) has a Piotroski F-Score of 8 as of Jun. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MeVis Medical Solutions AG and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, MeVis Medical Solutions AG's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, MeVis Medical Solutions AG ranks #17 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 2.6%.
Is MeVis Medical Solutions AG's Piotroski F-Score too high?
MeVis Medical Solutions AG's current Piotroski F-Score of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. MeVis Medical Solutions AG's value of 8 is 60% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #17 out of 652 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Piotroski F-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #17 out of 652 companies for Piotroski F-Score. This places MeVis Medical Solutions AG in the top 3% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. MeVis Medical Solutions AG's value of 8 is 60% above this benchmark. Historically, MeVis Medical Solutions AG's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Piotroski F-Score is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Piotroski F-Score of 8. The stock's GF Value™ is €22.52, compared to a current price of €23.20 — trading 3% above its estimated fair value. The current Piotroski F-Score is 8, which is 33% above median its 10-year median of 6.00 and 60% above the Healthcare Providers & Services industry median of 5.00. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Piotroski F-Score is 8 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?

Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued. The current stock price of €23.20 is trading 3% above its estimated GF Value™ of €22.52.

Key valuation signals for FRA:M3V:

  • Piotroski F-Score: 8 (33% above median its 10-year median of 6.00)
  • GF Value™: €22.52 vs. price of €23.20 (3% above fair value)
  • GF Score™: 66/100 with 4 warning signs
  • Industry Position: 60% above the Healthcare Providers & Services median (#17 of 652)

No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MeVis Medical Solutions AG Business Description

Other Exchanges 0HI7:UKM3V:Germany
Address Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score

Get the complete analysis for FRA:M3V

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.20
Price
€22.52
GF Value